European Journal of Cancer
Volume 41, Issue 18 , Pages 2819-2827 , December 2005

Placenta growth factor is over-expressed and has prognostic value in human breast cancer

  • Christian Parr

      Affiliations

    • Metastasis and Angiogenesis Research Group, Department of Surgery, Wales College of Medicine, Cardiff University, Heath Park, Cardiff CF14 4XN, UK
    • Corresponding Author InformationCorresponding author. Tel.: +44 29 2074 8394; fax: +44 29 2076 1623.
    • ,
  • Gareth Watkins

      Affiliations

    • Metastasis and Angiogenesis Research Group, Department of Surgery, Wales College of Medicine, Cardiff University, Heath Park, Cardiff CF14 4XN, UK
    • ,
  • Mike Boulton

      Affiliations

    • Cell and Molecular Biology Unit, School of Optometry and Vision Sciences, Redwood Building, King Edward VII Ave., Cardiff University, Cardiff, CF10 3NB, UK
    • ,
  • Jun Cai

      Affiliations

    • Cell and Molecular Biology Unit, School of Optometry and Vision Sciences, Redwood Building, King Edward VII Ave., Cardiff University, Cardiff, CF10 3NB, UK
    • ,
  • Wen G. Jiang

      Affiliations

    • Metastasis and Angiogenesis Research Group, Department of Surgery, Wales College of Medicine, Cardiff University, Heath Park, Cardiff CF14 4XN, UK

Received 11 March 2005 ,Revised 19 July 2005 ,Accepted 28 July 2005.

References 

  1. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100:57–70
  2. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell. 1996;86:353–364
  3. Ferrara N. VEGF and the quest for tumour angiogenesis factors. Nat Rev Cancer. 2002;2:795–803
  4. Dvorak HF. Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy. J Clin Oncol. 2002;20:4368–4380
  5. Plate KH, Breier G, Weich HA, et al. Vascular endothelial growth factor is a potential tumor angiogenesis factor in human gliomas in vivo. Nature. 1992;359:845–848
  6. Berse B, Brown LF, Van de Water L, et al. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Mol Biol Cell. 1992;3:211–220
  7. Zhang HT, Craft P, Scott PA, et al. Enhancement of tumor growth and vascular density by transfection of vascular endothelial cell growth factor into MCF-7 human breast carcinoma cell. J Natl Cancer Inst. 1995;87:213–219
  8. Maeda K, Chung YS, Ogawa Y, et al. Prognostic value of vascular endothelial growth factor expression in gastric carcinoma. Cancer. 1996;77:858–863
  9. Linderholm B, Tavelin B, Grankvist K, et al. Vascular endothelial growth factor is of high prognostic value in node negative breast carcinoma. J Clin Oncol. 1998;16:3121–3128
  10. Gasparani G, Toi M, Gion M. Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma. J Natl Cancer Inst. 1997;89:139–147
  11. Maglione D, Guerriero V, Viglietto G, et al. Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc Natl Acad Sci USA. 1991;88:9267–9271
  12. Cao Y, Weidong RJ, Pang Q, et al. Placenta growth factor: identification and characterization of a novel isoform generated by RNA alternative splicing. Biochem Biophys Res Commun. 1997;235:493–498
  13. Autiero M, Waltenberger J, Communi D, et al. Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1. Nat Med. 2003;9:936–943
  14. Carmeliet P, Moons L, Luttun A, et al. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med. 2001;7:575–583
  15. Luttun A, Autiero M, Tjwa M, et al. Genetic dissection of tumor angiogenesis: are PlGF and VEGFR-1 novel anti-cancer targets?. Biochim Biophys Acta. 2004;1654:79–94
  16. Hauser S, Weich HA. A heparin-binding form of placenta growth factor (PlGF-2) is expressed in human umbilical vein endothelial cells and in placenta. Growth Factors. 1993;9:259–268
  17. Vuorela P, Hatva E, Lymboussaki A. Expression of vascular endothelial growth factor and placenta growth factor in human placenta. Biol Reprod. 1997;56:489–494
  18. Rakic JM, Lambert V, Devy L, et al. Placental growth factor, a member of the VEGF family, contributes to the development of choroidal neovascularization. Ophthalmol Vis Sci. 2003;44:3186–3193
  19. Khaliq A, Foreman D, Ahmed A, et al. Increased expression of placenta growth factor in proliferative diabetic retinopathy. Lab Invest. 1998;78:109–116
  20. Li XF, Charnock-Jones DS, Zhang E, et al. Angiogenic growth factor messenger ribonucleic acids in uterine natural killer cells. J Clin Endocrinol Metab. 2001;86:1823–1834
  21. Roberts-Clark DJ, Smith AJ. Angiogenic growth factors in human dentine matrix. Arch Oral Biol. 2000;45:1013–1016
  22. Chen CN, Hsieh FJ, Cheng YM, et al. The significance of placenta growth factor in angiogenesis and clinical outcome of human gastric cancer. Cancer Lett. 2004;213:73–82
  23. Matsumoto K, Suzuki K, Koike H, et al. Prognostic significance of plasma placental growth factor levels in renal cell cancer: an association with clinical characteristics and vascular endothelial growth factor levels. Anticancer Res. 2003;23:4953–4958
  24. Donnini S, Machein MR, Plate KH, et al. Expression and localization of placenta growth factor and PlGF receptors in human meningiomas. J Pathol. 1999;189:66–71
  25. Lacal PM, Failla CM, Pagani E, et al. Human melanoma cells secrete and respond to placenta growth factor and vascular endothelial growth factor. J Invest Dermatol. 2000;115:1000–1007
  26. Nomura M, Yamagishi S, Harada S, et al. Placenta growth factor (PlGF) mRNA expression in brain tumors. J Neurooncol. 1998;4:123–130
  27. Takahashi A, Sasaki H, Kim SJ, et al. Markedly increased amounts of messenger RNAs for vascular endothelial growth factor and placenta growth factor in renal cell carcinoma associated with angiogenesis. Cancer Res. 1994;54:4233–4237
  28. Kodama J, Seki N, Tokumo K, et al. Placenta growth factor is abundantly expressed in human cervical squamous cell carcinoma. Eur J Gynaecol Oncol. 1997;18:508–510
  29. Viglietto G, Maglione D, Rambaldi M, et al. Upregulation of vascular endothelial growth factor (VEGF) and downregulation of placenta growth factor (PlGF) associated with malignancy in human thyroid tumors and cell lines. Oncogene. 1995;11:1569–1579
  30. Parr C, Watkins G, Mansel RE, et al. The hepatocyte growth factor regulatory factors and human breast cancer. Clin Cancer Res. 2004;10:202–211
  31. Jiang WG, Douglas-Jones A, Mansel RE. Level of expression of PPAR-gamma and its co-activator (PPAR-GCA) in human breast cancer. Int J Cancer. 2003;106:752–757
  32. Jiang WG, Hiscox S, Parr C, et al. Antagonistic effects of NK4, a novel HGF variant, on the in vitro angiogenesis of human vascular endothelial cells. Clin Cancer Res. 1999;5:3695–3703
  33. Cai J, Ahmad S, Jiang WG, et al. Activation of vascular endothelial growth factor receptor-1 sustains angiogenesis and Bcl-2 expression via the phosphatidylinositol 3-kinase pathway in endothelial cells. Diabetes. 2003;52:2959–2968
  34. Luttun A, Tjwa M, Moons L, et al. Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. Nat Med. 2002;8:831–840
  35. Carmeliet P. VEGF gene therapy: stimulating angiogenesis or angioma-genesis. Nat Med. 2001;6:1102–1103
  36. Odorisio T, Schietroma C, Zaccaria ML, et al. Mice overexpressing placenta growth factor exhibit increased vascularization and vessel permeability. J Cell Sci. 2002;115:2559–2567
  37. Luttun A, Autiero M, Tjwa M, et al. Genetic dissection of tumor angiogenesis: are PlGF and VEGFR-1 novel anti-cancer targets. Biochim Biophys Acta. 2004;1654:79–94
  38. Taylor AP, Osorio L, Craig R, et al. Tumor-specific regulation of angiogenic growth factors and their receptors during recovery from cytotoxic therapy. Clin Cancer Res. 2002;8:1213–1222
  39. Taylor AP, Rodriguez M, Adams K, et al. Altered tumor vessel maturation and proliferation in placenta growth factor-producing tumors: potential relationship to post-therapy tumor angiogenesis and recurrence. Int J Cancer. 2003;105:158–164

PII: S0959-8049(05)00793-8

doi: 10.1016/j.ejca.2005.07.022

European Journal of Cancer
Volume 41, Issue 18 , Pages 2819-2827 , December 2005

Article Tools

* Image Usage & Resolution